Global Chorionic Gonadotropin for Injection Market Growth 2022-2028
The global market for Chorionic Gonadotropin for Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Chorionic Gonadotropin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Chorionic Gonadotropin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Chorionic Gonadotropin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Chorionic Gonadotropin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Chorionic Gonadotropin for Injection players cover Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd. and Merck. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Chorionic Gonadotropin for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Chorionic Gonadotropin for Injection market, with both quantitative and qualitative data, to help readers understand how the Chorionic Gonadotropin for Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Chorionic Gonadotropin for Injection market and forecasts the market size by Type (u-hCG and r-hCG,), by Application (Hospital, Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
u-hCG
r-hCG
Segmentation by application
Hospital
Clinic
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Shanghai Livzon Pharmaceutical Co., Ltd.
Qingdao Guanlong Biopharmaceutical Co., Ltd.
Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Merck
Chapter Introduction
Chapter 1: Scope of Chorionic Gonadotropin for Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Chorionic Gonadotropin for Injection market size (sales and revenue) and CAGR, Chorionic Gonadotropin for Injection market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Chorionic Gonadotropin for Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Chorionic Gonadotropin for Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Chorionic Gonadotropin for Injection market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd. and Merck, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chorionic Gonadotropin for Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Chorionic Gonadotropin for Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Chorionic Gonadotropin for Injection by Country/Region, 2017, 2022 & 2028
2.2 Chorionic Gonadotropin for Injection Segment by Type
2.2.1 u-hCG
2.2.2 r-hCG
2.3 Chorionic Gonadotropin for Injection Sales by Type
2.3.1 Global Chorionic Gonadotropin for Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Chorionic Gonadotropin for Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Chorionic Gonadotropin for Injection Sale Price by Type (2017-2022)
2.4 Chorionic Gonadotropin for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Chorionic Gonadotropin for Injection Sales by Application
2.5.1 Global Chorionic Gonadotropin for Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Chorionic Gonadotropin for Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Chorionic Gonadotropin for Injection Sale Price by Application (2017-2022)
3 Global Chorionic Gonadotropin for Injection by Company
3.1 Global Chorionic Gonadotropin for Injection Breakdown Data by Company
3.1.1 Global Chorionic Gonadotropin for Injection Annual Sales by Company (2020-2022)
3.1.2 Global Chorionic Gonadotropin for Injection Sales Market Share by Company (2020-2022)
3.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Chorionic Gonadotropin for Injection Revenue by Company (2020-2022)
3.2.2 Global Chorionic Gonadotropin for Injection Revenue Market Share by Company (2020-2022)
3.3 Global Chorionic Gonadotropin for Injection Sale Price by Company
3.4 Key Manufacturers Chorionic Gonadotropin for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chorionic Gonadotropin for Injection Product Location Distribution
3.4.2 Players Chorionic Gonadotropin for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Chorionic Gonadotropin for Injection by Geographic Region
4.1 World Historic Chorionic Gonadotropin for Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Chorionic Gonadotropin for Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Geographic Region
4.2 World Historic Chorionic Gonadotropin for Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Chorionic Gonadotropin for Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Country/Region
4.3 Americas Chorionic Gonadotropin for Injection Sales Growth
4.4 APAC Chorionic Gonadotropin for Injection Sales Growth
4.5 Europe Chorionic Gonadotropin for Injection Sales Growth
4.6 Middle East & Africa Chorionic Gonadotropin for Injection Sales Growth
5 Americas
5.1 Americas Chorionic Gonadotropin for Injection Sales by Country
5.1.1 Americas Chorionic Gonadotropin for Injection Sales by Country (2017-2022)
5.1.2 Americas Chorionic Gonadotropin for Injection Revenue by Country (2017-2022)
5.2 Americas Chorionic Gonadotropin for Injection Sales by Type
5.3 Americas Chorionic Gonadotropin for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chorionic Gonadotropin for Injection Sales by Region
6.1.1 APAC Chorionic Gonadotropin for Injection Sales by Region (2017-2022)
6.1.2 APAC Chorionic Gonadotropin for Injection Revenue by Region (2017-2022)
6.2 APAC Chorionic Gonadotropin for Injection Sales by Type
6.3 APAC Chorionic Gonadotropin for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Chorionic Gonadotropin for Injection by Country
7.1.1 Europe Chorionic Gonadotropin for Injection Sales by Country (2017-2022)
7.1.2 Europe Chorionic Gonadotropin for Injection Revenue by Country (2017-2022)
7.2 Europe Chorionic Gonadotropin for Injection Sales by Type
7.3 Europe Chorionic Gonadotropin for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chorionic Gonadotropin for Injection by Country
8.1.1 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Chorionic Gonadotropin for Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Type
8.3 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chorionic Gonadotropin for Injection
10.3 Manufacturing Process Analysis of Chorionic Gonadotropin for Injection
10.4 Industry Chain Structure of Chorionic Gonadotropin for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chorionic Gonadotropin for Injection Distributors
11.3 Chorionic Gonadotropin for Injection Customer
12 World Forecast Review for Chorionic Gonadotropin for Injection by Geographic Region
12.1 Global Chorionic Gonadotropin for Injection Market Size Forecast by Region
12.1.1 Global Chorionic Gonadotropin for Injection Forecast by Region (2023-2028)
12.1.2 Global Chorionic Gonadotropin for Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chorionic Gonadotropin for Injection Forecast by Type
12.7 Global Chorionic Gonadotropin for Injection Forecast by Application
13 Key Players Analysis
13.1 Shanghai Livzon Pharmaceutical Co., Ltd.
13.1.1 Shanghai Livzon Pharmaceutical Co., Ltd. Company Information
13.1.2 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Offered
13.1.3 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Shanghai Livzon Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Shanghai Livzon Pharmaceutical Co., Ltd. Latest Developments
13.2 Qingdao Guanlong Biopharmaceutical Co., Ltd.
13.2.1 Qingdao Guanlong Biopharmaceutical Co., Ltd. Company Information
13.2.2 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Offered
13.2.3 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Qingdao Guanlong Biopharmaceutical Co., Ltd. Main Business Overview
13.2.5 Qingdao Guanlong Biopharmaceutical Co., Ltd. Latest Developments
13.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
13.3.1 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Company Information
13.3.2 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product Offered
13.3.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Main Business Overview
13.3.5 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Latest Developments
13.4 Ningbo Renjian Pharmaceutical Group Co., Ltd.
13.4.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Information
13.4.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product Offered
13.4.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Main Business Overview
13.4.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Chorionic Gonadotropin for Injection Product Offered
13.5.3 Merck Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Chorionic Gonadotropin for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Chorionic Gonadotropin for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of u-hCG
Table 4. Major Players of r-hCG
Table 5. Global Chorionic Gonadotropin for Injection Sales by Type (2017-2022) & (K Units)
Table 6. Global Chorionic Gonadotropin for Injection Sales Market Share by Type (2017-2022)
Table 7. Global Chorionic Gonadotropin for Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Chorionic Gonadotropin for Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Chorionic Gonadotropin for Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Chorionic Gonadotropin for Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Chorionic Gonadotropin for Injection Sales Market Share by Application (2017-2022)
Table 12. Global Chorionic Gonadotropin for Injection Revenue by Application (2017-2022)
Table 13. Global Chorionic Gonadotropin for Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Chorionic Gonadotropin for Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Chorionic Gonadotropin for Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Chorionic Gonadotropin for Injection Sales Market Share by Company (2020-2022)
Table 17. Global Chorionic Gonadotropin for Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Chorionic Gonadotropin for Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Chorionic Gonadotropin for Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Chorionic Gonadotropin for Injection Producing Area Distribution and Sales Area
Table 21. Players Chorionic Gonadotropin for Injection Products Offered
Table 22. Chorionic Gonadotropin for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Chorionic Gonadotropin for Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Chorionic Gonadotropin for Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Chorionic Gonadotropin for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Chorionic Gonadotropin for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Chorionic Gonadotropin for Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Chorionic Gonadotropin for Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Chorionic Gonadotropin for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Chorionic Gonadotropin for Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Chorionic Gonadotropin for Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Chorionic Gonadotropin for Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Chorionic Gonadotropin for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Chorionic Gonadotropin for Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Chorionic Gonadotropin for Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Chorionic Gonadotropin for Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Chorionic Gonadotropin for Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Chorionic Gonadotropin for Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Chorionic Gonadotropin for Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Chorionic Gonadotropin for Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Chorionic Gonadotropin for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Chorionic Gonadotropin for Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Chorionic Gonadotropin for Injection Sales by Type (2017-2022) & (K Units)
Table 46. APAC Chorionic Gonadotropin for Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Chorionic Gonadotropin for Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Chorionic Gonadotropin for Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Chorionic Gonadotropin for Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Chorionic Gonadotropin for Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Chorionic Gonadotropin for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Chorionic Gonadotropin for Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Chorionic Gonadotropin for Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Chorionic Gonadotropin for Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Chorionic Gonadotropin for Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Chorionic Gonadotropin for Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Chorionic Gonadotropin for Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Chorionic Gonadotropin for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Chorionic Gonadotropin for Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Chorionic Gonadotropin for Injection Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Chorionic Gonadotropin for Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Chorionic Gonadotropin for Injection
Table 66. Key Market Challenges & Risks of Chorionic Gonadotropin for Injection
Table 67. Key Industry Trends of Chorionic Gonadotropin for Injection
Table 68. Chorionic Gonadotropin for Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Chorionic Gonadotropin for Injection Distributors List
Table 71. Chorionic Gonadotropin for Injection Customer List
Table 72. Global Chorionic Gonadotropin for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Chorionic Gonadotropin for Injection Sales Market Forecast by Region
Table 74. Global Chorionic Gonadotropin for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Chorionic Gonadotropin for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Chorionic Gonadotropin for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Chorionic Gonadotropin for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Chorionic Gonadotropin for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Chorionic Gonadotropin for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Chorionic Gonadotropin for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Chorionic Gonadotropin for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Chorionic Gonadotropin for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Chorionic Gonadotropin for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Chorionic Gonadotropin for Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Chorionic Gonadotropin for Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Chorionic Gonadotropin for Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Chorionic Gonadotropin for Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Chorionic Gonadotropin for Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Chorionic Gonadotropin for Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Chorionic Gonadotropin for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Chorionic Gonadotropin for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Shanghai Livzon Pharmaceutical Co., Ltd. Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Offered
Table 94. Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Shanghai Livzon Pharmaceutical Co., Ltd. Main Business
Table 96. Shanghai Livzon Pharmaceutical Co., Ltd. Latest Developments
Table 97. Qingdao Guanlong Biopharmaceutical Co., Ltd. Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Offered
Table 99. Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Qingdao Guanlong Biopharmaceutical Co., Ltd. Main Business
Table 101. Qingdao Guanlong Biopharmaceutical Co., Ltd. Latest Developments
Table 102. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product Offered
Table 104. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Main Business
Table 106. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Latest Developments
Table 107. Ningbo Renjian Pharmaceutical Group Co., Ltd. Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product Offered
Table 109. Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Ningbo Renjian Pharmaceutical Group Co., Ltd. Main Business
Table 111. Ningbo Renjian Pharmaceutical Group Co., Ltd. Latest Developments
Table 112. Merck Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Merck Chorionic Gonadotropin for Injection Product Offered
Table 114. Merck Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Merck Main Business
Table 116. Merck Latest Developments
List of Figures
Figure 1. Picture of Chorionic Gonadotropin for Injection
Figure 2. Chorionic Gonadotropin for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chorionic Gonadotropin for Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Chorionic Gonadotropin for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Chorionic Gonadotropin for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of u-hCG
Figure 10. Product Picture of r-hCG
Figure 11. Global Chorionic Gonadotropin for Injection Sales Market Share by Type in 2021
Figure 12. Global Chorionic Gonadotropin for Injection Revenue Market Share by Type (2017-2022)
Figure 13. Chorionic Gonadotropin for Injection Consumed in Hospital
Figure 14. Global Chorionic Gonadotropin for Injection Market: Hospital (2017-2022) & (K Units)
Figure 15. Chorionic Gonadotropin for Injection Consumed in Clinic
Figure 16. Global Chorionic Gonadotropin for Injection Market: Clinic (2017-2022) & (K Units)
Figure 17. Chorionic Gonadotropin for Injection Consumed in Others
Figure 18. Global Chorionic Gonadotropin for Injection Market: Others (2017-2022) & (K Units)
Figure 19. Global Chorionic Gonadotropin for Injection Sales Market Share by Application (2017-2022)
Figure 20. Global Chorionic Gonadotropin for Injection Revenue Market Share by Application in 2021
Figure 21. Chorionic Gonadotropin for Injection Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Chorionic Gonadotropin for Injection Revenue Market Share by Company in 2021
Figure 23. Global Chorionic Gonadotropin for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Chorionic Gonadotropin for Injection Revenue Market Share by Geographic Region in 2021
Figure 25. Global Chorionic Gonadotropin for Injection Sales Market Share by Region (2017-2022)
Figure 26. Global Chorionic Gonadotropin for Injection Revenue Market Share by Country/Region in 2021
Figure 27. Americas Chorionic Gonadotropin for Injection Sales 2017-2022 (K Units)
Figure 28. Americas Chorionic Gonadotropin for Injection Revenue 2017-2022 ($ Millions)
Figure 29. APAC Chorionic Gonadotropin for Injection Sales 2017-2022 (K Units)
Figure 30. APAC Chorionic Gonadotropin for Injection Revenue 2017-2022 ($ Millions)
Figure 31. Europe Chorionic Gonadotropin for Injection Sales 2017-2022 (K Units)
Figure 32. Europe Chorionic Gonadotropin for Injection Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Chorionic Gonadotropin for Injection Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Chorionic Gonadotropin for Injection Revenue 2017-2022 ($ Millions)
Figure 35. Americas Chorionic Gonadotropin for Injection Sales Market Share by Country in 2021
Figure 36. Americas Chorionic Gonadotropin for Injection Revenue Market Share by Country in 2021
Figure 37. United States Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Chorionic Gonadotropin for Injection Sales Market Share by Region in 2021
Figure 42. APAC Chorionic Gonadotropin for Injection Revenue Market Share by Regions in 2021
Figure 43. China Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Chorionic Gonadotropin for Injection Sales Market Share by Country in 2021
Figure 50. Europe Chorionic Gonadotropin for Injection Revenue Market Share by Country in 2021
Figure 51. Germany Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Chorionic Gonadotropin for Injection Revenue Market Share by Country in 2021
Figure 58. Egypt Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Chorionic Gonadotropin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Chorionic Gonadotropin for Injection in 2021
Figure 64. Manufacturing Process Analysis of Chorionic Gonadotropin for Injection
Figure 65. Industry Chain Structure of Chorionic Gonadotropin for Injection
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets